Equifax Valuation
Is EFX * undervalued compared to its fair value, analyst forecasts and its price relative to the market?
Valuation Score
2/6Valuation Score 2/6
Below Fair Value
Significantly Below Fair Value
Price-To-Earnings vs Peers
Price-To-Earnings vs Industry
Price-To-Earnings vs Fair Ratio
Analyst Forecast
Share Price vs Fair Value
What is the Fair Price of EFX * when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.
Below Fair Value: EFX * (MX$5962.59) is trading below our estimate of fair value (MX$8043.61)
Significantly Below Fair Value: EFX * is trading below fair value by more than 20%.
Key Valuation Metric
Which metric is best to use when looking at relative valuation for EFX *?
Other financial metrics that can be useful for relative valuation.
| What is EFX *'s n/a Ratio? | |
|---|---|
| n/a | 0x |
| n/a | n/a |
| Market Cap | US$35.93b |
| Key Statistics | |
|---|---|
| Enterprise Value/Revenue | 7.6x |
| Enterprise Value/EBITDA | 24.6x |
| PEG Ratio | 2.6x |
Price to Earnings Ratio vs Peers
How does EFX *'s PE Ratio compare to its peers?
| Company | Forward PE | Estimated Growth | Market Cap |
|---|---|---|---|
| Peer Average | 37.5x | ||
VRSK Verisk Analytics | 41.9x | 8.2% | US$37.7b |
WKL Wolters Kluwer | 35.6x | 7.2% | €36.9b |
EXPN Experian | 40.1x | 10.7% | UK£35.9b |
SGSN SGS | 32.4x | 12.3% | CHF 17.7b |
EFX * Equifax | 61.6x | 23.8% | Mex$35.9b |
Price-To-Earnings vs Peers: EFX * is expensive based on its Price-To-Earnings Ratio (61.6x) compared to the peer average (37.5x).
Price to Earnings Ratio vs Industry
How does EFX *'s PE Ratio compare vs other companies in the Global Professional Services Industry?
Price-To-Earnings vs Industry: EFX * is expensive based on its Price-To-Earnings Ratio (61.6x) compared to the Global Professional Services industry average (21x).
Price to Earnings Ratio vs Fair Ratio
What is EFX *'s PE Ratio compared to its Fair PE Ratio? This is the expected PE Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.
| Fair Ratio | |
|---|---|
| Current PE Ratio | 61.6x |
| Fair PE Ratio | n/a |
Price-To-Earnings vs Fair Ratio: Insufficient data to calculate EFX *'s Price-To-Earnings Fair Ratio for valuation analysis.
Analyst Price Targets
What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?
| Date | Share Price | Average 1Y Price Target | Dispersion | High | Low | 1Y Actual price | Analysts |
|---|---|---|---|---|---|---|---|
| Current | Mex$5,962.59 | Mex$5,974.39 +0.2% | 8.2% | Mex$7,330.73 | Mex$5,208.68 | n/a | 19 |
| Sep ’25 | n/a | Mex$5,864.50 0% | 8.5% | Mex$6,873.83 | Mex$4,556.36 | n/a | 20 |
| Aug ’25 | n/a | Mex$5,321.94 0% | 8.1% | Mex$5,876.38 | Mex$4,113.47 | n/a | 20 |
| Jul ’25 | n/a | Mex$4,806.31 0% | 8.3% | Mex$5,632.86 | Mex$4,005.59 | n/a | 18 |
| Jun ’25 | n/a | Mex$4,560.00 0% | 8.3% | Mex$5,344.20 | Mex$3,800.32 | n/a | 18 |
| May ’25 | n/a | Mex$4,568.80 0% | 8.2% | Mex$5,361.30 | Mex$3,812.48 | n/a | 19 |
| Apr ’25 | n/a | Mex$4,655.05 0% | 9.4% | Mex$5,247.59 | Mex$3,718.29 | n/a | 19 |
| Mar ’25 | n/a | Mex$4,748.35 0% | 9.6% | Mex$5,360.86 | Mex$3,744.09 | n/a | 21 |
| Feb ’25 | n/a | Mex$4,513.27 0% | 11.6% | Mex$5,402.50 | Mex$3,550.22 | n/a | 21 |
| Jan ’25 | n/a | Mex$3,928.25 0% | 16.4% | Mex$5,348.76 | Mex$2,784.75 | n/a | 21 |
| Dec ’24 | n/a | Mex$3,687.21 0% | 12.7% | Mex$4,643.19 | Mex$2,820.31 | n/a | 20 |
| Nov ’24 | n/a | Mex$3,775.06 0% | 13.9% | Mex$4,868.05 | Mex$2,956.89 | n/a | 19 |
| Oct ’24 | n/a | Mex$3,932.34 0% | 12.4% | Mex$5,054.99 | Mex$2,963.27 | n/a | 19 |
| Sep ’24 | n/a | Mex$3,949.40 0% | 11.9% | Mex$4,971.79 | Mex$2,914.50 | n/a | 20 |
| Aug ’24 | n/a | Mex$3,842.81 0% | 11.9% | Mex$4,837.61 | Mex$2,835.84 | n/a | 20 |
| Jul ’24 | n/a | Mex$3,890.41 0% | 13.2% | Mex$5,392.64 | Mex$2,824.72 | n/a | 20 |
| Jun ’24 | n/a | Mex$3,944.51 0% | 14.3% | Mex$5,571.85 | Mex$2,830.14 | n/a | 20 |
| May ’24 | n/a | Mex$4,024.07 0% | 14.8% | Mex$5,700.71 | Mex$2,805.11 | n/a | 20 |
| Apr ’24 | n/a | Mex$4,016.38 0% | 15.2% | Mex$5,677.06 | Mex$2,703.36 | n/a | 20 |
| Mar ’24 | n/a | Mex$4,122.85 0% | 15.5% | Mex$5,799.12 | Mex$2,761.49 | n/a | 19 |
| Feb ’24 | Mex$4,100.12 | Mex$4,004.64 -2.3% | 16.2% | Mex$5,929.69 | Mex$2,823.66 | n/a | 19 |
| Jan ’24 | n/a | Mex$4,039.19 0% | 18.5% | Mex$6,188.11 | Mex$2,946.72 | n/a | 18 |
| Dec ’23 | n/a | Mex$3,881.43 0% | 19.1% | Mex$6,096.32 | Mex$2,903.01 | n/a | 18 |
| Nov ’23 | n/a | Mex$3,829.86 0% | 18.7% | Mex$6,277.92 | Mex$2,989.49 | n/a | 18 |
| Oct ’23 | n/a | Mex$4,564.02 0% | 12.6% | Mex$6,444.32 | Mex$3,423.55 | n/a | 19 |
| Sep ’23 | n/a | Mex$4,569.76 0% | 11.4% | Mex$6,350.66 | Mex$3,572.24 | n/a | 19 |
Analyst Forecast: Target price is less than 20% higher than the current share price.